274 related articles for article (PubMed ID: 31419466)
1. Empaglifozin mitigates NAFLD in high-fat-fed mice by alleviating insulin resistance, lipogenesis and ER stress.
Petito-da-Silva TI; Souza-Mello V; Barbosa-da-Silva S
Mol Cell Endocrinol; 2019 Dec; 498():110539. PubMed ID: 31419466
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE
Nasiri-Ansari N; Nikolopoulou C; Papoutsi K; Kyrou I; Mantzoros CS; Kyriakopoulos G; Chatzigeorgiou A; Kalotychou V; Randeva MS; Chatha K; Kontzoglou K; Kaltsas G; Papavassiliou AG; Randeva HS; Kassi E
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467546
[TBL] [Abstract][Full Text] [Related]
3. Anti-steatotic linagliptin pleiotropic effects encompasses suppression of de novo lipogenesis and ER stress in high-fat-fed mice.
Santos FO; Correia BRO; Marinho TS; Barbosa-da-Silva S; Mandarim-de-Lacerda CA; Souza-Mello V
Mol Cell Endocrinol; 2020 Jun; 509():110804. PubMed ID: 32259637
[TBL] [Abstract][Full Text] [Related]
4. Bisphenol-A exposure worsens hepatic steatosis in ovariectomized mice fed on a high-fat diet: Role of endoplasmic reticulum stress and fibrogenic pathways.
Figueiredo LS; Oliveira KM; Freitas IN; Silva JA; Silva JN; Favero-Santos BC; Bonfleur ML; Carneiro EM; Ribeiro RA
Life Sci; 2020 Sep; 256():118012. PubMed ID: 32593710
[TBL] [Abstract][Full Text] [Related]
5. GW0742 (PPAR-beta agonist) attenuates hepatic endoplasmic reticulum stress by improving hepatic energy metabolism in high-fat diet fed mice.
Silva-Veiga FM; Rachid TL; de Oliveira L; Graus-Nunes F; Mandarim-de-Lacerda CA; Souza-Mello V
Mol Cell Endocrinol; 2018 Oct; 474():227-237. PubMed ID: 29580823
[TBL] [Abstract][Full Text] [Related]
6. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.
Xu L; Nagata N; Chen G; Nagashimada M; Zhuge F; Ni Y; Sakai Y; Kaneko S; Ota T
BMJ Open Diabetes Res Care; 2019; 7(1):e000783. PubMed ID: 31749970
[TBL] [Abstract][Full Text] [Related]
7. Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway.
Jung TW; Kim HC; Abd El-Aty AM; Jeong JH
J Biol Chem; 2018 Mar; 293(11):3981-3988. PubMed ID: 29414781
[TBL] [Abstract][Full Text] [Related]
8. Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats.
Swe MT; Thongnak L; Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Lungkaphin A
Clin Sci (Lond); 2019 Dec; 133(23):2415-2430. PubMed ID: 31769484
[TBL] [Abstract][Full Text] [Related]
9. Hydroxytyrosol ameliorates insulin resistance by modulating endoplasmic reticulum stress and prevents hepatic steatosis in diet-induced obesity mice.
Wang N; Liu Y; Ma Y; Wen D
J Nutr Biochem; 2018 Jul; 57():180-188. PubMed ID: 29747118
[TBL] [Abstract][Full Text] [Related]
10. Exercise enhances hepatic mitochondrial structure and function while preventing endoplasmic reticulum stress and metabolic dysfunction-associated steatotic liver disease in mice fed a high-fat diet.
Souza-Tavares H; Santana-Oliveira DA; Vasques-Monteiro IML; Silva-Veiga FM; Mandarim-de-Lacerda CA; Souza-Mello V
Nutr Res; 2024 Jun; 126():180-192. PubMed ID: 38759501
[TBL] [Abstract][Full Text] [Related]
11. In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia.
Hüttl M; Markova I; Miklankova D; Zapletalova I; Poruba M; Haluzik M; Vaněčkova I; Malinska H
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768942
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Mc1 improves liver steatosis and insulin resistance by attenuating ER stress.
Roh E; Hwang HJ; Kim JW; Hong SH; Kim JA; Lee YB; Choi KM; Baik SH; Yoo HJ
J Ethnopharmacol; 2020 Sep; 259():112927. PubMed ID: 32387461
[TBL] [Abstract][Full Text] [Related]
13. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y
Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650
[TBL] [Abstract][Full Text] [Related]
14. Long-term exposure to high-sucrose diet down-regulates hepatic endoplasmic reticulum-stress adaptive pathways and potentiates de novo lipogenesis in weaned male mice.
Flister KFT; Pinto BAS; França LM; Coêlho CFF; Dos Santos PC; Vale CC; Kajihara D; Debbas V; Laurindo FRM; Paes AMA
J Nutr Biochem; 2018 Dec; 62():155-166. PubMed ID: 30300835
[TBL] [Abstract][Full Text] [Related]
15. Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease.
Lee N; Heo YJ; Choi SE; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
Biochem Biophys Res Commun; 2022 Jan; 588():154-160. PubMed ID: 34971904
[TBL] [Abstract][Full Text] [Related]
16. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
[TBL] [Abstract][Full Text] [Related]
17. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
[TBL] [Abstract][Full Text] [Related]
18. Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.
de Oliveira PR; da Costa CA; de Bem GF; Cordeiro VS; Santos IB; de Carvalho LC; da Conceição EP; Lisboa PC; Ognibene DT; Sousa PJ; Martins GR; da Silva AJ; de Moura RS; Resende AC
PLoS One; 2015; 10(12):e0143721. PubMed ID: 26630290
[TBL] [Abstract][Full Text] [Related]
19. The Sodium-Glucose Co-Transporter 2 Inhibitor, Empagliflozin, Protects against Diabetic Cardiomyopathy by Inhibition of the Endoplasmic Reticulum Stress Pathway.
Zhou Y; Wu W
Cell Physiol Biochem; 2017; 41(6):2503-2512. PubMed ID: 28472796
[TBL] [Abstract][Full Text] [Related]
20. Exogenous administration of unacylated ghrelin attenuates hepatic steatosis in high-fat diet-fed rats by modulating glucose homeostasis, lipogenesis, oxidative stress, and endoplasmic reticulum stress.
Alharbi S
Biomed Pharmacother; 2022 Jul; 151():113095. PubMed ID: 35594708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
